|
Market Closed -
Nasdaq
04:00:00 17/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.570 USD | -3.75% |
|
-26.78% | +80.99% |
| 10-16 | Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo | CI |
| 08-20 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EDSA | Delayed | |
CBOE
| EDSA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 3.56 | 5.75 | 17.59 |
| Spread/Res. | -27.81% | -55.30% | -85.39% |
| Spread/Supp. | -3.02% | -3.02% | +221.25% |
| Support | 2.65 | 2.65 | 0.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EDSA Stock
- Charts Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
